{
  "gene": "P2RX5",
  "analysis_method": "DeepSeek API with RAG",
  "existing_diseases_count": 0,
  "existing_diseases": [],
  "pubmed_context_available": true,
  "pubmed_context_length": 2966,
  "query": "\nYou are a genetics expert. Analyze the P2RX5 gene comprehensively using ONLY the provided literature context.\n\n\n**IMPORTANT: Base your analysis STRICTLY on the provided PubMed literature context below. Do NOT hallucinate or make up information not supported by the literature.**\n\n**Retrieved PubMed Literature Context:**\n# PubMed Search Results for: P2RX5\n# Found 5 articles\n# ==================================================\n\n1. Ann Endocrinol (Paris). 2025 Sep 10:102456. doi: 10.1016/j.ando.2025.102456. \nOnline ahead of print.\n\nAnalysis of genetic predisposition to familial non-medullary thyroid cancer by \nwhole genome sequencing.\n\nCao CD(1), Desailloud R(2), Topolinski H(3), Crépin M(4), Flament C(4), \nLeteurtre E(5), Cardot-Bauters C(1), Frénois F(6), Ait-Yahya É(7), Bonte F(7), \nLeclerc J(8), Pigny P(9).\n\n---\n\nCopyright © 2025 The Author(s). Published by Elsevier Masson SAS.. All rights \nreserved.\n\nDOI: 10.1016/j.ando.2025.102456\nPMID: 40939960\n\n\n2. Int J Mol Sci. 2025 Jul 4;26(13):6474. doi: 10.3390/ijms26136474.\n\nThe Purinergic Receptor P2X5 Modulates Glucose Metabolism and Expression of \nThermogenic Genes in Brown Adipose Tissue.\n\nJaeckstein MY(1), Miegel L(1), Behrens J(1), Stähler T(2), Diercks BP(1), Heine \nM(1), Koch-Nolte F(2), Heeren J(1).\n\nAuthor information:\n(1)Department of Biochemistry and Molecular Cell Biology, University Medical \nCenter Hamburg-Eppendorf, 20246 Hamburg, Germany.\n(2)Institute of Immunology, University Medical Center Hamburg-Eppendorf, 20246 \nHamburg, Germany.\n\n---\n\ndiscovered a key gene, the purinergic receptor P2 × 5 (P2RX5), which \nsignificantly contributes to meat quality traits. We identified five SNP sites \nwithin the P2RX5 gene and conducted genotyping. Three of these SNP sites were \nfound to be significantly associated with meat quality traits in chickens, such \nas the a*value and cooking loss. These results indicated that our findings \nprovide potential molecular markers for changing meat quality traits in \nchickens. However, due to our small sample size and the absence of testing on \nmales, the generalizability of the results may be insufficient.\n\n---\n\nBoth external dataset analysis and experimental validation corroborated the \ndifferential expression of BLK and P2RX5 in patients with MS.\nCONCLUSION: BLK, P2RX5, GP1BA, and PF4 emerge as potential predictors of future \ndisease activity in individuals with MS.\n\n---\n\ntissue and predicted to impact protein function were identified in patients from \nboth families. In F8, the best candidate was the P2RX5 p.Leu32Gln variant \npreviously reported in another PTC family. However, its relatively high MAF in \nEuropean controls (0.43%) casts doubt on its pathogenic role. In F17, the most \nrelevant variant was c.345del in MST1R encoding the tyrosine kinase receptor \nRON. The variant is predicted to encode a truncated isoform. Further analysis of \ntumor and germline DNA showed no clear evidence of an expression switch from the \nlong to the short oncogenic RON isoform.\nCONCLUSION: Our data provide novel insight on the genetics of FNMTC. The P2RX5 \np.Leu32Gln variant should be considered either as low-penetrant or not \nassociated with PTC predisposition. MST1R appears as a new putative \nsusceptibility gene for FNMTC that warrants further consideration.\n\n\n\n**Analysis requested (base ONLY on provided literature):**\n\n1. **Molecular Function & Structure**:\n   - What is P2RX5's primary molecular function according to the literature?\n   - What protein domains does it contain?\n   - How does it regulate cellular processes?\n\n2. **Disease Mechanisms**:\n   - How do P2RX5 mutations cause disease based on the studies?\n   - What are the key pathogenic mechanisms described?\n   - Are there genotype-phenotype correlations mentioned?\n\n3. **Clinical Phenotypes**:\n   - What clinical features are described in the literature?\n   - How do different mutation types affect phenotype?\n   - What inheritance patterns are reported?\n\n4. **Research Findings**:\n   - What are the key discoveries about P2RX5 in the literature?\n   - Any disease associations mentioned?\n   - Therapeutic approaches discussed?\n\n5. **Literature Limitations**:\n   - What aspects of P2RX5 are NOT covered in the provided context?\n   - What additional research is needed?\n\n**CRITICAL: Only cite information that is explicitly mentioned in the provided PubMed context. If information is not available in the context, clearly state this limitation.**\n",
  "analysis": "Based strictly on the provided PubMed literature context, here is a comprehensive analysis of the P2RX5 gene:\n\n### 1. Molecular Function & Structure\n- **Primary Molecular Function**: The literature identifies P2RX5 as a **purinergic receptor** that modulates glucose metabolism and the expression of thermogenic genes in brown adipose tissue.\n- **Protein Domains**: The provided context does not describe the specific protein domains of P2RX5.\n- **Cellular Process Regulation**: It is described as modulating processes in brown adipose tissue related to glucose metabolism and thermogenesis. The context does not provide further details on the mechanisms of this regulation.\n\n### 2. Disease Mechanisms\n- **How Mutations Cause Disease**: A specific variant, **P2RX5 p.Leu32Gln**, was investigated in the context of familial non-medullary thyroid cancer (FNMTC). However, the literature concludes that this variant is either of **low penetrance or not associated with PTC predisposition**, casting doubt on its direct pathogenic role due to its relatively high minor allele frequency (MAF of 0.43%) in European controls.\n- **Key Pathogenic Mechanisms**: No specific pathogenic mechanisms for P2RX5 mutations are detailed in the provided context.\n- **Genotype-Phenotype Correlations**: The context does not describe any clear genotype-phenotype correlations for P2RX5.\n\n### 3. Clinical Phenotypes\n- **Clinical Features**: The literature associates P2RX5 with:\n    - **Familial Non-Medullary Thyroid Cancer (FNMTC)**, though the p.Leu32Gln variant's role is questionable.\n    - **Multiple Sclerosis (MS)**, where P2RX5 is identified as a potential predictor of future disease activity.\n    - **Meat quality traits in chickens** (e.g., a*value and cooking loss), though this is an animal model finding.\n- **Effect of Different Mutation Types**: Only the p.Leu32Gln missense variant is mentioned; its effect is considered minimal or non-pathogenic for PTC. No other mutation types are discussed.\n- **Inheritance Patterns**: The context does not specify any inheritance patterns for P2RX5-related conditions.\n\n### 4. Research Findings\n- **Key Discoveries**:\n    - P2RX5 is a modulator of glucose metabolism and thermogenic gene expression in brown adipose tissue.\n    - In chickens, specific SNP sites in P2RX5 are significantly associated with meat quality traits.\n    - In multiple sclerosis, P2RX5 is differentially expressed and emerges as a potential predictor of disease activity.\n    - In FNMTC, the P2RX5 p.Leu32Gln variant is not a strong candidate for disease predisposition.\n- **Disease Associations**:\n    - Familial Non-Medullary Thyroid Cancer (FNMTC)\n    - Multiple Sclerosis (MS)\n    - Meat quality traits in chickens (veterinary/agricultural context)\n- **Therapeutic Approaches**: The provided context does not discuss any therapeutic approaches targeting P2RX5.\n\n### 5. Literature Limitations\n- **Aspects Not Covered**: The provided literature does not address:\n    - The full molecular structure, protein domains, or detailed signaling pathways of P2RX5.\n    - Comprehensive pathogenic mechanisms or how P2RX5 dysfunction leads to disease.\n    - Genotype-phenotype correlations, inheritance patterns, or clinical management guidelines.\n    - Therapeutic strategies or drug interactions involving P2RX5.\n    - The role of P2RX5 in tissues or diseases beyond those mentioned (e.g., neurological, immune, or other cancer types beyond thyroid and MS).\n- **Additional Research Needed** (as implied by the context):\n    - Further validation of P2RX5's role in FNMTC due to the uncertain pathogenicity of the p.Leu32Gln variant.\n    - Larger-scale studies in chickens to confirm the association with meat quality traits and improve generalizability.\n    - More research to confirm P2RX5 as a predictor in multiple sclerosis and explore its mechanistic role.\n    - Functional studies to understand how P2RX5 modulates metabolism and thermogenesis in brown adipose tissue.\n\nThis analysis is strictly limited to the information explicitly presented in the provided PubMed literature context. Any aspects not mentioned above are not covered in the available literature.",
  "timestamp": "2025-10-01 15:59:00"
}